Astria Therapeutics (ATXS) Gross Profit: 2014-2018
Historic Gross Profit for Astria Therapeutics (ATXS) over the last 5 years, with Dec 2018 value amounting to -$100,000.
- Astria Therapeutics' Gross Profit fell 104.00% to -$10,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $150,000, marking a year-over-year change of. This contributed to the annual value of -$100,000 for FY2018, which is 120.00% down from last year.
- Per Astria Therapeutics' latest filing, its Gross Profit stood at -$100,000 for FY2018, which was down 120.00% from $500,000 recorded in FY2017.
- In the past 5 years, Astria Therapeutics' Gross Profit ranged from a high of $500,000 in FY2017 and a low of -$978,000 during FY2015.
- Over the past 3 years, Astria Therapeutics' median Gross Profit value was -$100,000 (recorded in 2018), while the average stood at -$145,667.
- As far as peak fluctuations go, Astria Therapeutics' Gross Profit plummeted by 374.76% in 2015, and later surged by 159.74% in 2017.
- Yearly analysis of 5 years shows Astria Therapeutics' Gross Profit stood at -$206,000 in 2014, then plummeted by 374.76% to -$978,000 in 2015, then rose by 14.42% to -$837,000 in 2016, then soared by 159.74% to $500,000 in 2017, then slumped by 120.00% to -$100,000 in 2018.